HPV-Vaccines / / edited by Gloria Calagna.

Human papillomavirus (HPV) is closely linked with the pathogenesis of cervical cancer and many other cancers. HPV vaccines are vaccines that prevent infection from certain types of human papillomavirus. However, despite the various prevention strategies and treatments, such as HPV screening, prophyl...

Full description

Saved in:
Bibliographic Details
TeilnehmendeR:
Place / Publishing House:[Place of publication not identified] : : MDPI - Multidisciplinary Digital Publishing Institute,, 2023.
Year of Publication:2023
Language:English
Physical Description:1 online resource (214 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993610551304498
ctrlnum (CKB)5470000002907834
(NjHacI)995470000002907834
(EXLCZ)995470000002907834
collection bib_alma
record_format marc
spelling HPV-Vaccines / edited by Gloria Calagna.
[Place of publication not identified] : MDPI - Multidisciplinary Digital Publishing Institute, 2023.
1 online resource (214 pages)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on publisher supplied metadata and other sources.
Human papillomavirus (HPV) is closely linked with the pathogenesis of cervical cancer and many other cancers. HPV vaccines are vaccines that prevent infection from certain types of human papillomavirus. However, despite the various prevention strategies and treatments, such as HPV screening, prophylactic HPV vaccines, surgery, radiotherapy, and chemotherapy, the disease burden remains heavy worldwide. Currently, three types of prophylactic vaccines-quadrivalent HPV vaccines, bivalent HPV vaccines, and a new nonavalent HPV vaccine-are commercially available. Although these vaccines protect against 90% of HPV infections, their capacity to eliminate pre-existing infections is limited. In this Topical Collection, we aim to systematically cover the progress, current status, and future prospects of various vaccines being developed for the prevention and treatment of HPV-associated lesions and cancers.
Vaccines.
Papillomaviruses.
3-0365-5918-3
Calagna, Gloria, editor.
language English
format eBook
author2 Calagna, Gloria,
author_facet Calagna, Gloria,
author2_variant g c gc
author2_role TeilnehmendeR
title HPV-Vaccines /
spellingShingle HPV-Vaccines /
title_full HPV-Vaccines / edited by Gloria Calagna.
title_fullStr HPV-Vaccines / edited by Gloria Calagna.
title_full_unstemmed HPV-Vaccines / edited by Gloria Calagna.
title_auth HPV-Vaccines /
title_new HPV-Vaccines /
title_sort hpv-vaccines /
publisher MDPI - Multidisciplinary Digital Publishing Institute,
publishDate 2023
physical 1 online resource (214 pages)
isbn 3-0365-5918-3
callnumber-first Q - Science
callnumber-subject QR - Microbiology
callnumber-label QR406
callnumber-sort QR 3406 H688 42023
illustrated Not Illustrated
dewey-hundreds 500 - Science
dewey-tens 570 - Life sciences; biology
dewey-ones 576 - Genetics & evolution
dewey-full 576.6484
dewey-sort 3576.6484
dewey-raw 576.6484
dewey-search 576.6484
work_keys_str_mv AT calagnagloria hpvvaccines
status_str n
ids_txt_mv (CKB)5470000002907834
(NjHacI)995470000002907834
(EXLCZ)995470000002907834
carrierType_str_mv cr
is_hierarchy_title HPV-Vaccines /
author2_original_writing_str_mv noLinkedField
_version_ 1796653284186914817
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01847nam a2200289 i 4500</leader><controlfield tag="001">993610551304498</controlfield><controlfield tag="005">20230816114832.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230816s2023 xx o 000 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5470000002907834</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995470000002907834</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995470000002907834</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QR406</subfield><subfield code="b">.H688 2023</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">576.6484</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">HPV-Vaccines /</subfield><subfield code="c">edited by Gloria Calagna.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">[Place of publication not identified] :</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute,</subfield><subfield code="c">2023.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (214 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Human papillomavirus (HPV) is closely linked with the pathogenesis of cervical cancer and many other cancers. HPV vaccines are vaccines that prevent infection from certain types of human papillomavirus. However, despite the various prevention strategies and treatments, such as HPV screening, prophylactic HPV vaccines, surgery, radiotherapy, and chemotherapy, the disease burden remains heavy worldwide. Currently, three types of prophylactic vaccines-quadrivalent HPV vaccines, bivalent HPV vaccines, and a new nonavalent HPV vaccine-are commercially available. Although these vaccines protect against 90% of HPV infections, their capacity to eliminate pre-existing infections is limited. In this Topical Collection, we aim to systematically cover the progress, current status, and future prospects of various vaccines being developed for the prevention and treatment of HPV-associated lesions and cancers.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Vaccines.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Papillomaviruses.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-5918-3</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Calagna, Gloria,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-08-18 03:30:30 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2023-07-04 13:45:39 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5346844360004498&amp;Force_direct=true</subfield><subfield code="Z">5346844360004498</subfield><subfield code="b">Available</subfield><subfield code="8">5346844360004498</subfield></datafield></record></collection>